The Gross Margin of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd (600613.SS) is 49.22%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-12-31 | 49.22% |
| 2024-12-31 | 46.47% |
| 2023-12-31 | 49.22% |